Visit-to-visit glycemic variability better predicts future complications in type 2 diabetes |
Journal Updates
eMediNexus Coverage from: 
Visit-to-visit glycemic variability better predicts future complications in type 2 diabetes

1 Read Comments                

Long-term visit-to-visit glycemic variability is a better risk predictor of future micro- and macrovascular complications in patients with type 2 diabetes than mean HbA1c levels, suggests the Rio de Janeiro Type 2 Diabetes Cohort Study published February 24, 2018 in the journal Cardiovascular Diabetology.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now